Literature DB >> 29994657

Optimized Echo Decorrelation Imaging Feedback for Bulk Ultrasound Ablation Control.

Mohamed A Abbass, Allison-Joy Garbo, Neeraja Mahalingam, Jakob K Killin, T Douglas Mast.   

Abstract

Feasibility of controlling bulk ultrasound (US) thermal ablation using echo decorrelation imaging was investigated in ex vivo bovine liver. The first of two ablation and control procedures used a sequence of constant-intensity sonication cycles, ceased when the minimum echo decorrelation within a control region of interest (ROI) exceeded a predetermined threshold. The second procedure used a variable-intensity sonication sequence, with spatially averaged decorrelation as the stopping criterion. US exposures and echo decorrelation imaging were performed by a linear image-ablate array. Based on preliminary experiments, control ROIs and thresholds for the minimum-decorrelation and average-decorrelation criteria were specified. Controlled trials for the minimum-decorrelation and average-decorrelation criteria were compared with uncontrolled trials employing 9 or 18 cycles of matching sonication sequences. Lesion dimensions, treatment times, ablation rates, and areas under receiver operating characteristic curves were statistically compared. Successfully controlled trials using both criteria required significantly shorter treatment times than corresponding 18-cycle treatments, with better ablation prediction performance than uncontrolled 9-cycle and 18-cycle treatments. Either control approach resulted in greater ablation rate than corresponding 9-cycle or 18-cycle uncontrolled approaches. A post hoc analysis studied the effect of exchanging control criteria between the two series of controlled experiments. For either group, the average time needed to exceed the alternative decorrelation threshold approximately matched the average duration of successfully controlled experimental trials. These results indicate that either approach, using minimum-decorrelation or average-decorrelation criteria, is feasible for control of bulk US ablation. In addition, use of a variable-intensity sonication sequence for bulk US thermal ablation can result in larger ablated regions compared to constant-intensity sonication sequences.

Entities:  

Mesh:

Year:  2018        PMID: 29994657      PMCID: PMC6294441          DOI: 10.1109/TUFFC.2018.2847599

Source DB:  PubMed          Journal:  IEEE Trans Ultrason Ferroelectr Freq Control        ISSN: 0885-3010            Impact factor:   2.725


  41 in total

1.  Feasibility of a Low-Power Radiofrequency Ablation Protocol to Delay Steam Popping.

Authors:  Jooae Choe; Kyung Won Kim; Young Il Kim; Jin Wook Chung; Jimi Huh; Jisuk Park; Su Jung Ham; Myong Ki Jun; Pyo Nyun Kim
Journal:  J Vasc Interv Radiol       Date:  2015-12-03       Impact factor: 3.464

2.  Ultrasound monitoring of in vitro radio frequency ablation by echo decorrelation imaging.

Authors:  T Douglas Mast; Daniel P Pucke; Swetha E Subramanian; William J Bowlus; Steven M Rudich; Joseph F Buell
Journal:  J Ultrasound Med       Date:  2008-12       Impact factor: 2.153

3.  Monitoring during hepatic radiofrequency ablation (RFA): comparison of real-time ultrasound elastography (RTE) and contrast-enhanced ultrasound (CEUS): first clinical results of 25 patients.

Authors:  P Wiggermann; K Brünn; J Rennert; M Loss; H Wobser; A G Schreyer; C Stroszczynski; E M Jung
Journal:  Ultraschall Med       Date:  2013-10-16       Impact factor: 6.548

4.  Realtime control of multiple-focus phased array heating patterns based on noninvasive ultrasound thermography.

Authors:  Andrew Casper; Dalong Liu; Emad S Ebbini
Journal:  IEEE Trans Biomed Eng       Date:  2011-07-14       Impact factor: 4.538

5.  Automatic temperature control for MR-guided interstitial ultrasound ablation in liver using a percutaneous applicator: ex vivo and in vivo initial studies.

Authors:  Eric Delabrousse; Rares Salomir; Alain Birer; Christian Paquet; François Mithieux; Jean-Yves Chapelon; François Cotton; Cyril Lafon
Journal:  Magn Reson Med       Date:  2010-03       Impact factor: 4.668

6.  MR-guided microwave ablation in hepatic tumours: initial results in clinical routine.

Authors:  Rüdiger Hoffmann; Hansjörg Rempp; David-Emanuel Keßler; Jakob Weiß; Philippe L Pereira; Konstantin Nikolaou; Stephan Clasen
Journal:  Eur Radiol       Date:  2016-08-23       Impact factor: 5.315

7.  Gauging the likelihood of stable cavitation from ultrasound contrast agents.

Authors:  Kenneth B Bader; Christy K Holland
Journal:  Phys Med Biol       Date:  2012-12-07       Impact factor: 3.609

8.  Effectiveness of impedance monitoring during radiofrequency ablation for predicting popping.

Authors:  Hiroya Iida; Tsukasa Aihara; Shinichi Ikuta; Naoki Yamanaka
Journal:  World J Gastroenterol       Date:  2012-11-07       Impact factor: 5.742

9.  Comparison of real-time contrast-enhanced ultrasonography and standard ultrasonography in liver cancer microwave ablation.

Authors:  Shi-Yan Yan; Yi Zhang; Chao Sun; Hai-Xia Cao; Guang-Ming Li; Yu-Qin Wang; Jian-Gao Fan
Journal:  Exp Ther Med       Date:  2016-06-10       Impact factor: 2.447

10.  Adaptive ultrasound temperature imaging for monitoring radiofrequency ablation.

Authors:  Yi-Da Liu; Qiang Li; Zhuhuang Zhou; Yao-Wen Yeah; Chien-Cheng Chang; Chia-Yen Lee; Po-Hsiang Tsui
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

View more
  3 in total

1.  Three-dimensional echo decorrelation monitoring of radiofrequency ablation in ex vivo bovine liver.

Authors:  E Ghahramani Z; P D Grimm; K J Eary; M P Swearengen; E G Sunethra K Dayavansha; T D Mast
Journal:  J Acoust Soc Am       Date:  2022-06       Impact factor: 2.482

2.  Effect of Overpressure on Acoustic Emissions and Treated Tissue Histology in ex Vivo Bulk Ultrasound Ablation.

Authors:  Chandra Priya Karunakaran; Mark T Burgess; Marepalli B Rao; Christy K Holland; T Douglas Mast
Journal:  Ultrasound Med Biol       Date:  2021-05-20       Impact factor: 3.694

3.  In vivo ultrasound thermal ablation control using echo decorrelation imaging in rabbit liver and VX2 tumor.

Authors:  Mohamed A Abbass; Syed A Ahmad; Neeraja Mahalingam; K Sameer Krothapalli; Jack A Masterson; Marepalli B Rao; Peter G Barthe; T Douglas Mast
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.